Niagen Bioscience

Update in progress

NAGE (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Niagen Bioscience, Inc. is a bioscience company focused on healthy aging products. It operates in three segments: Consumer Products, Ingredients, and Pharmaceuticals. The company provides finished dietary supplements containing proprietary ingredients and raw materials to manufacturers, and develops food-grade and pharmaceutical-grade Niagen and NAD+ technologies. It markets NAD+ precursor nicotinamide riboside as the NIAGEN brand, sells direct-to-consumer via TRUNIAGEN.com and other outlets, and was formerly ChromaDex. Founded in 1999, it is headquartered in Los Angeles, California.

Company score

Sentiment: 0.38; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.20; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.15; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.09; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.24; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive